# Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1

> **NCT01239706** · PHASE2 · UNKNOWN · sponsor: **University of Calgary** · enrollment: 10 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** NTx 265

## Key facts

- **NCT ID:** NCT01239706
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2010-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01239706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01239706, "Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01239706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*